Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram.
Elevated plasma levels of asymmetric dimethylarginine (ADMA) have been reported to be associated with endothelial dysfunction, inflammation, and oxidative stress in multiple cardiovascular diseases. This study aimed to investigate whether ADMA was a predictor of clinical outcomes in atrial fibrillat...
Main Authors: | Tze-Fan Chao, Tse-Min Lu, Yenn-Jiang Lin, Hsuan-Ming Tsao, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Ta-Chuan Tuan, Ming-Hsiung Hsieh, Shih-Ann Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3737156?pdf=render |
Similar Items
-
Effect of fish oil on circulating asymmetric dimethylarginine and adiponectin in overweight or obese patients with atrial fibrillation
by: Elnaz Khorrami, et al.
Published: (2020-04-01) -
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
by: You‐Lin Tain, et al.
Published: (2017-03-01) -
The clinical and electroanatomical characteristics of paroxysmal lone atrial fibrillation
by: Ta-Chuan Tuan, et al.
Published: (2012-06-01) -
Epicardial adipose tissue thickness and ablation outcome of atrial fibrillation.
by: Tze-Fan Chao, et al.
Published: (2013-01-01) -
Asymmetric dimethylarginine and polymorphisms/common haplotypes of dimethylarginine dimethylaminohydrolase 1 gene and risk of cardiovascular disease
by: Tse-Min Lu, et al.
Published: (2011)